---
title: "Lazard's Global Head of Healthcare David Gluckman Discusses Investment and Innovation on The Ripple Effect Podcast"
description: "Lazard Inc.’s Global Head of Healthcare, David Gluckman, discussed investment and innovation in the global healthcare sector on The Ripple Effect podcast. Joined by experts from Novartis, the conversa"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/261082763.md"
published_at: "2025-10-14T13:25:21.000Z"
---

# Lazard's Global Head of Healthcare David Gluckman Discusses Investment and Innovation on The Ripple Effect Podcast

> Lazard Inc.’s Global Head of Healthcare, David Gluckman, discussed investment and innovation in the global healthcare sector on The Ripple Effect podcast. Joined by experts from Novartis, the conversation focused on the intersection of healthcare and capital markets, highlighting the importance of strategic investment in advancing medical progress. The episode emphasizes Lazard’s insights into the evolving forces shaping the industry.

Lazard Inc.’s Global Head of Healthcare, David Gluckman, recently participated in a discussion on The Ripple Effect podcast, produced by GZERO Media in partnership with Novartis. Joined by Dan Riskin, PhD, and Patrick Horber, President of Novartis International, Gluckman explored the evolving forces shaping investment, innovation, and transformation in the global healthcare sector. The conversation highlighted Lazard’s perspective on the intersection of healthcare and capital markets, emphasizing the role of strategic investment in driving medical progress worldwide. Listen to the full episode here (here). Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lazard Inc. published the original content used to generate this news brief on October 14, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [LAZ.US - Lazard](https://longbridge.com/en/quote/LAZ.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Lazard Nears Inflection As Bank Of America Initiates Coverage At Buy | Lazard Inc (NYSE:LAZ) is nearing a pivotal point, according to Bank of America analyst Ebrahim Poonawala, who initiated  | [Link](https://longbridge.com/en/news/273725775.md) |
| Earnings Flash (LAZ) Lazard, Inc. Reports Q3 Revenue $748.1M, vs. FactSet Est of $717.6M | Earnings Flash (LAZ) Lazard, Inc. Reports Q3 Revenue $748.1M, vs. FactSet Est of $717.6M | [Link](https://longbridge.com/en/news/262408271.md) |
| Jorie AI Shares a Live Case Study on the Inevitable Future of Healthcare AI at ViVE 2026 | Jorie AI showcased its autonomous healthcare AI solutions at ViVE 2026, emphasizing the need for AI to operate effective | [Link](https://longbridge.com/en/news/275497445.md) |
| Where Were The Job Opportunities In 2025? Where Will They Be In 2026? | In 2025, job growth was minimal, with only Education and Health Care (+697,000 jobs) and Leisure and Hospitality (+119,0 | [Link](https://longbridge.com/en/news/275986113.md) |
| A Look At Acadia Healthcare (ACHC) Valuation After David Einhorn Stake And Leadership Changes | Acadia Healthcare (ACHC) gained attention after David Einhorn disclosed a new stake, leading to increased trading volume | [Link](https://longbridge.com/en/news/275994576.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.